164 related articles for article (PubMed ID: 1383844)
1. Morphometrical analysis of GFAP-positive cells in human astrocytomas.
Yoshii Y; Narushima K; Tsurushima H; Yanaka K; Hyodo A; Nose T; Sugiyama K; Sakamura S
Neurol Med Chir (Tokyo); 1992 Jul; 32(8):554-8. PubMed ID: 1383844
[TBL] [Abstract][Full Text] [Related]
2. Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo.
Holland EC; Li Y; Celestino J; Dai C; Schaefer L; Sawaya RA; Fuller GN
Am J Pathol; 2000 Sep; 157(3):1031-7. PubMed ID: 10980141
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms.
Nduom EK; Yang C; Merrill MJ; Zhuang Z; Lonser RR
J Neurosurg; 2013 Aug; 119(2):427-33. PubMed ID: 23621605
[TBL] [Abstract][Full Text] [Related]
4. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological study on malignant glioma--with special reference to GFAP].
Tajika T; Kubo O; Tajika Y; Toyama T; Himuro H; Inoue N; Sakairi M; Kitamura K
No Shinkei Geka; 1986 Jun; 14(7):831-5. PubMed ID: 3020463
[TBL] [Abstract][Full Text] [Related]
6. Expression of neuronal markers, NFP and GFAP, in malignant astrocytoma.
Hashemi F; Naderian M; Kadivar M; Nilipour Y; Gheytanchi E
Asian Pac J Cancer Prev; 2014; 15(15):6315-9. PubMed ID: 25124617
[TBL] [Abstract][Full Text] [Related]
7. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of peroxiredoxin 1, peroxiredoxin 6 and GFAP in human brain astrocytoma and their clinical significance].
Zhou J; Liu Q; Wang J; Guo X; Song L
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1255-9. PubMed ID: 22985558
[TBL] [Abstract][Full Text] [Related]
9. A2B5 lineages of human astrocytic tumors and their recurrence.
Xia CL; Du ZW; Liu ZY; Huang Q; Chan WY
Int J Oncol; 2003 Aug; 23(2):353-61. PubMed ID: 12851684
[TBL] [Abstract][Full Text] [Related]
10. Pathologic analysis of primary brain tumors.
McComb RD; Burger PC
Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
[TBL] [Abstract][Full Text] [Related]
11. J1-31 protein expression in astrocytes and astrocytomas.
Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
[TBL] [Abstract][Full Text] [Related]
12. Diffusion Kurtosis Imaging Reflects Glial Fibrillary Acidic Protein (GFAP), Topo IIα, and O⁶-Methylguanine-DNA Methyltransferase (MGMT) Expression in Astrocytomas.
Wang XC; Lei Y; Wang L; Tan Y; Qin JB; Ma GL; Zhang H
Med Sci Monit; 2018 Dec; 24():8822-8830. PubMed ID: 30520434
[TBL] [Abstract][Full Text] [Related]
13. A histopathological diagnostic marker for human spinal astrocytoma: expression of glial fibrillary acidic protein-δ.
Heo DH; Kim SH; Yang KM; Cho YJ; Kim KN; Yoon DH; Kang TC
J Neurooncol; 2012 May; 108(1):45-52. PubMed ID: 22318658
[TBL] [Abstract][Full Text] [Related]
14. Keratin expression in astrocytomas: an immunofluorescent and biochemical reassessment.
Kriho VK; Yang HY; Moskal JR; Skalli O
Virchows Arch; 1997 Aug; 431(2):139-47. PubMed ID: 9293896
[TBL] [Abstract][Full Text] [Related]
15. Low-grade astrocytomas may arise from different astrocyte lineages.
Piepmeier JM; Fried I; Makuch R
Neurosurgery; 1993 Oct; 33(4):627-32. PubMed ID: 8232801
[TBL] [Abstract][Full Text] [Related]
16. Vimentin and glial fibrillary acidic protein in human brain tumors.
Yung WK; Luna M; Borit A
J Neurooncol; 1985; 3(1):35-8. PubMed ID: 3889231
[TBL] [Abstract][Full Text] [Related]
17. Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression.
Wilhelmsson U; Eliasson C; Bjerkvig R; Pekny M
Oncogene; 2003 May; 22(22):3407-11. PubMed ID: 12776191
[TBL] [Abstract][Full Text] [Related]
18. Proteins of the intermediate filament cytoskeleton as markers for astrocytes and human astrocytomas.
Yang HY; Lieska N; Shao D; Kriho V; Pappas GD
Mol Chem Neuropathol; 1994; 21(2-3):155-76. PubMed ID: 7522006
[TBL] [Abstract][Full Text] [Related]
19. Astrocyte-astrocytoma cell line interactions in culture.
Lal PG; Ghirnikar RS; Eng LF
J Neurosci Res; 1996 May; 44(3):216-22. PubMed ID: 8723760
[TBL] [Abstract][Full Text] [Related]
20. Contactin is expressed in human astrocytic gliomas and mediates repulsive effects.
Eckerich C; Zapf S; Ulbricht U; Müller S; Fillbrandt R; Westphal M; Lamszus K
Glia; 2006 Jan; 53(1):1-12. PubMed ID: 16078236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
